StockGlow

NeuroSense Therapeutics Ltd. (NRSNW)

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally.

$0.10+0.00%
Compare NRSNW with
StockGlow Score
50
Neutral
BearishBullish
1 year ago-52.2%

The outlook

Analyst and trend data are thin for NRSNW right now, so there isn't enough to form a clear read. Check back later as coverage updates.

What’s behind the score

Analyst and trend data are thin for this ticker right now.

Market cap
—
52-wk high
$0.10
52-wk low
$0.10
50-day avg
—
200-day avg
—
Trailing P/E
—

Similar stocks

NRSNNeuroSense Therapeutics Ltd.$0.46-2.94%REVBWRevelation Biosciences, Inc.$0.01+0.00%NTRBWNutriband Inc.$0.25-28.57%KTTAWPasithea Therapeutics Corp.$0.01+0.00%NLSPWNLS Pharmaceutics Ltd.$0.02

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy